Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHD

CONTEXT: Recombinant human growth hormone (rhGH) is approved for treatment of pediatric growth hormone deficiency (GHD), with greatest growth responses observed in those with severe GHD. Orally administered GH secretagogues (GHS) may be useful treatment in patients with moderate GHD. Distinguishing...

Descripción completa

Detalles Bibliográficos
Autores principales: Blum, Werner F, Bright, George M, Do, Minh-Ha T, McKew, John C, Chen, Haiying, Thorner, Michael O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101276/
https://www.ncbi.nlm.nih.gov/pubmed/33982678
http://dx.doi.org/10.1210/jendso/bvab029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101276/
https://www.ncbi.nlm.nih.gov/pubmed/33982678
http://dx.doi.org/10.1210/jendso/bvab029

Ejemplares similares